Novel Bio is pioneering the production of plasmid DNA (pDNA) using a proprietary bacterial strain that is significantly more productive than traditional E. coli. Novel Bio’s platform reduces manufacturing cycle times for complex DNA sequences, making it a cost-effective solution for industries including industrial chemicals, cannabinoids, and pharmaceuticals.